Prioritizing vaccine boosters for vulnerable patients could prevent emergence of new COVID variants
Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine ...
AstraZeneca initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Sarita Kapila initiated coverage of AstraZeneca (AZN) with an Overweight rating and 14,500 GBp price target The firm ...
Morgan Stanley sets AstraZeneca stock Overweight with £145 target
AstraZeneca PLC (LON:AZN:LN) (NASDAQ: AZN), a pharmaceutical giant with a market capitalization of $224.5 billion, received a new Overweight rating from Morgan Stanley (NYSE:MS), accompanied by a ...